Trial
NCT03439033
Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
Cancer Research & Treatment Fund, Inc.
Condition
Prostate Cancer
Intervention
PET/MRI with Gallium-68 labeled PSMA-HBED-CC
Why stopped
Study Drug was FDA approved Summer 2021
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-13